|
Home : Unsafe Drugs : Avandia : Newsfeeds : GlaxoSmithKline Q1 Profit Rises Despite Lower Sales - Update GlaxoSmithKline Q1 Profit Rises Despite Lower Sales - Update
As we have previously signaled, there will be some volatility in quarterly margins during the year as sales from pandemic products, Avandia and Valtrex decrease." The company said it is on track for 2012 annualized restructuring benefits target of 2.2 billion pounds.
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




